First JCI & NABH Accredited Multispeciality Health Care Hospital in Gurgaon

Book Appointments On Application

      For Appointments: +91-124 4511 111 |    Emergency: +91-124 4588 888
    Whatsapp Icon  For Whatsapp Enquiry: +91 9599285476                                                  

Dr. Lalit Kumar

Dr. Lalit Kumar
Designation: Chairperson - Oncology & BMT
Specialty :
BMT, Oncology
Location :
Nationality :
Languages Spoken :
English, Hindi
Gender :
Artemis Hospitals

MBBS & MD (Medicine) - Sarojini Naidu Medical College, Agra.

DM Medical Oncology - Adyar Cancer Institute, Chennai

Post-Doctoral Fellowship - Royal Postgraduate Medical School of the Hammersmith Hospital, London.

Fulbright Scholarship - United States of America.


An illustrious academician, a visionary oncologist, a name that needs no introduction in the field of Stem Cells Transplant, Dr. Lalit Kumar; Artemis Hospitals is highly honoured to have him on board.

Lalit Kumar joins us from AIIMS, All India Institute of Medical Sciences, New Delhi, where he was associated as Professor and Head in the Department of Medical Oncology. He has experience in the field of Blood Stem Cell / Bone Marrow Transplantation, Haematological Malignancies, (Multiple Myeloma, Chronic Myeloid Leukaemia, Infections in cancer ovary, and servix) and Gynecological Malignancies where he studied Role of Neo-Adjuvant Chemotherapy.

is known to have developed cost-effective treatment protocols for sustained bone marrow and stem cell transplantations.


Padma Shri Award (2014).

Dr. B.C. Roy Award (2008) - the highest award by the Indian government in the medical category.

Indian Council of Medical Research (ICMR) Award.

Ranbaxy Science Foundation Award.

Fellowship: Indian Academy of Sciences (FASc).

Fellowship: National Academy of Medical Sciences of India (FAMS).

Fellowship: National Academy of Sciences (FNASI).

Membership :

Indo British Health Initiative (IBHI)

Institute of Women's Health (IFWH) of the University College of London (UCL)

Expert Committee to examine the Serious Adverse Events (SAE) of deaths occurring during clinical trials

© 2024 Artemis Hospitals | Digital Partner